Four medical facilities in the U.S. are engaging in a $13 million clinical trial to study stem cell treatment for osteoarthritis in the knee, reports WKRG.

Bioventus launched a disease and product information website called OAKneePainRelief.com to provide information on knee osteoarthritis for patients and providers.

Orthocell noted positive interim clinical results for CelGro, its collagen-based scaffold to support tissue growth and repair, reports Small Caps.

At the North American Spine Society Annual Meeting, in a Sept. 25 panel session titled "BMP in 2019 – The Biologic Hasn't Changed but the Evidence Has," a group of physicians discussed the state of BMP today.

Stem cell-focused oncology company Vor Biopharma made a series of appointments to its leadership team.

The Spine Journal, the official journal of the North American Spine Society, published a DiscGenics study examining preclinical testing for Discogenic Cells, reports OA Online.

Rosalind Franklin University's Chicago Medical School recognized Wayne Olan, MD, as a distinguished alumnus.

Royal Biologics recently launched the Maxx Ultra Cord with clinical applications in spine and neurosurgery.

Drug company Catalent named David Schaffer, PhD, to its biologics advisory board.

Google will no longer allow advertisements for unproven or experimental medical procedures in its search results to prevent clinics from misleading patients, The Verge reports.

Here are four treatments that are in development in the biologics space:

Drugmakers Grünenthal and Mesoblast entered into a partnership to develop a biologics-based treatment for chronic lower back pain.

NervGen Pharma is planning its clinical development strategy for its compound, NVG-291, in spinal cord injury and multiple sclerosis patients.

The U.S. Patent and Trademark Office issued a patent for Lineage Cell Therapeutics' stem cell-derived treatment for spinal cord injury.

Duchenne UK awarded researchers from Minneapolis-based University of Minnesota Medical School $945,000 to advance their work around a stem cell-based therapy to treat Duchenne muscular dystrophy.

A column by the right-leaning Independent Institute concerned the California Institute for Regenerative Medicine.

Here are five key developments in stem cell treatments for spine and orthopedics.

Fairlawn, Ohio-based Crystal Clinic Orthopaedic Center is using biologic therapies to treat anterior cruciate ligament and joint-related injuries.

Richard Kim, MD, is using stem cells to help relieve patient pain at his private practice in Saratoga Springs, N.Y.

Ortho Regenerative Technologies reported a successful pre-investigational drug meeting with the FDA in February and is now preparing for its rotator cuff phase I/II clinical trial.